Glenmark reduced Favipiravir price to Rs 75 per tab from Rs 103 per tab earlier

Quick Update:

Glenmark sells the drug, used in the treatment of COVID-19, under the brand name FabiFlu. The oral antiviral favipiravir has been approved under emergency use authorization for the treatment of mild to moderate COVID-19 patients.

Glenmark Pharmaceuticals has said that it has reduced the price of its favipiravir drug to Rs 75 per tablet from Rs 103 per tablet it was charging earlier.